Call for proposals implementation of the agenda for medical ionising radiation applications (Samira action plan) – organisation of clinical audit campaigns as a tool to improve quality and safety of medical applications of ionising (CR-g-23-44-01)
Programme Category
Programme Name
Programme Description
The Programme aims to improve and promote health in the Union to reduce the burden of communicable and non-communicable diseases by:
- protecting people from serious cross-border health threats
- improving the availability, accessibility and affordability of medicines, medical devices and other crisis-related products in the EU
- strengthening national health systems
Identifier Code
Call
Summary
This topic focuses on the implementation of the agenda for medical ionising radiation applications (Samira action plan) – organisation of clinical audit campaigns as a tool to improve quality and safety of medical applications of ionising.
Detailed Call Description
This action is part of the Cancer Strand.
The objective of this action is to pilot clinical audit campaigns in Member States in diagnostic and interventional radiology, radiotherapy and nuclear medicine by identifying and bringing together relevant actors and resources. It should take into account the specificities of the national health systems.
Up to four proposals of different sizes will be accepted, ranging from organising pilot audits in a single (large) department or hospital, a hospital trust, a region or a single Member State to coordinated audits in several Member States and should be implemented in coordination with the appropriate health authorities. A priority will be given to proposals covering several types of medical practice in several Member States and also to different practices within different regions of a Member State.
Proposals should include considerations and activities to scale up pilot outcomes into the broader health system practice of Member State(s).
Call Total Budget
Financing percentage by EU or other bodies / Level of Subsidy or Loan
The costs will be reimbursed at the funding rate fixed in the Grant Agreement (60%). Your organisation can apply for a higher project funding rate (80%) if your project is of “exceptional utility”. Actions shall be considered to have exceptional utility where at least 30% of the budget of the proposed action is allocated to Member States whose GNI per inhabitant is less than 90% of the Union average; or the project concerns actions with bodies from at least 14 Member States and where at least 4 are from Member States whose GNI per inhabitant is less than 90% of the EU average.
Thematic Categories
- Health
- Public Administration
- Research, Technological Development and Innovation
- Small-Medium Enterprises and Competitiveness
Eligibility for Participation
- Associations
- Educational Institutions
- International Organisations
- Local Authorities
- Other Beneficiaries
- Private Bodies
- Researchers/Research Centers/Institutions
- State-owned Enterprises
Eligibility For Participation Notes
Applications will only be considered eligible if their content corresponds wholly (or at least in part) to the topic description for which it is submitted.
In order to be eligible, the applicants (beneficiaries and affiliated entities) must:
- be legal entities (public or private bodies)
- be established in one of the eligible countries, i.e.:
- EU Member States (including overseas countries and territories (OCTs)
- eligible non-EU countries:
- listed EEA countries and countries associated to the EU4Health Programme or countries which are in ongoing negotiations for an association agreement and where the agreement enters into force before grant signature (list of participating countries)
Type of applicants targeted: Academia (e.g. public health institutes) and education establishments, research institutes, hospitals, professional societies, competent authorities and established networks in the field pf public health.
Specific eligibility and selection criteria applicable to the consortium composition: Applications may be submitted either by a single applicant or a consortium.
In both cases (single applicants or consortium) the proposal must include one eligible applicant with expertise in at least one of the following medical specialties: radiology, radiotherapy, nuclear medicine, other medical specialties using ionising radiation.
This needs to be clearly highlighted in the proposal.
Call Opening Date
Call Closing Date
National Contact Point(s)
Ministry of Health, Department of European Affairs
Ms MAKRIGIORGI Elena
emakrigiorgi@moh.gov.cy
EU Contact Point
Stefan DE KEERSMAECKER
+32 2 298 46 80
stefan.de-keersmaecker@ec.europa.eu
Darragh CASSIDY
+32 2 298 39 78